Farallon Capital Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,654
Closed -$777K 318
2022
Q1
$777K Sell
6,654
-20,346
-75% -$3.37M ﹤0.01% 228
2021
Q4
$7M Hold
27,000
0.04% 164
2021
Q3
$7.37M Hold
27,000
0.03% 153
2021
Q2
$11.5M Sell
27,000
-3,000
-10% -$1.14M 0.05% 122
2021
Q1
$11.6M Buy
+30,000
New +$13.5M 0.06% 129

Other funds holding DRIO

Farallon Capital Management's DRIO Position: Q2 2022 in Review

Farallon Capital Management sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 6,654 shares — an estimated $777K sold.

Farallon Capital Management first reported a position in DRIO in Q1 2021 and held it in 5 quarters. The position peaked at $11.6M in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • Farallon Capital Management reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • Farallon Capital Management sold 6,654 DarioHealth shares in Q2 2022, an estimated $777K.
  • Farallon Capital Management first reported a position in DarioHealth in Q1 2021 and held it in 5 quarters.
  • Farallon Capital Management's DarioHealth position peaked at $11.6M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.